04 March 2021

GSK Stockmann advises FAY Projects on the sale of the “Future Living” quarter in Leipzig

FAY Projects develops a hotel and a Co-Living concept on the site at Berliner Strasse 22-30 near Leipzig’s main station. GSK Stockmann provided legal advice on the sale to the pension fund of the State Medical Association of Hesse as part of a Forward Deal.

The “Future Living” project, designed by TCHOBAN VOSS Architekten, will be built close to the city, 600 m northeast of Leipzig’s main station. Along Berliner Straße, a closed hotel development is planned. The three-star superior Radisson Hotel will have 224 guest rooms distributed over seven storeys. In the inner area facing the Parthe river, a building complex will be created consisting of three buildings with five to six storeys, which will be connected by three-storey intermediate buildings. This building complex will comprise 75 apartments with 185 rooms. Tenant is the Quarters Group, which will run the building complex as a Co-Living concept with furnished apartments and common areas. In the basement, Apcoa will run a public car park with 84 parking slots. The project, totaling 13,700 m² GFA, is scheduled for completion in mid-2023.

A team led by GSK Stockmann Partner Dr. Olaf Schmechel provided legal and tax advice to FAY Projects on the sale, in particular on the negotiation and drafting of the purchase agreement.

Advisers of FAY Projects:
GSK Stockmann: Dr. Olaf Schmechel (lead, Real Estate), Dominik Berka (Tax); Associates: Çağlayan Birkan (Real Estate)

Image source: FAY Projects GmbH

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 June 2023

    GSK Update: Comprehensive VAT exemption for management of alternative investment funds (AIFs) planned in Germany

    Read more
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
Contact person
Olaf Schmechel

Dr. Olaf Schmechel

Partner*

+49 30 203907-15

olaf.schmechel@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral